Hoch, Eva
Murawski, Monika
Ferri, Marica
Feingold, Daniel
Funding for this research was provided by:
European Drugs Agency (CT.21.HEA.0103.1)
Klinikum der Universität München
Article History
Received: 6 August 2024
Accepted: 11 January 2025
First Online: 4 March 2025
Declarations
:
: DF has been acting as consultant to EUDA and the Israeli government (2020-2024). He declares receiving compensation for presentations. MM have no interests. EH has been acting as consultant to the EUDA, WHO, UNOCD and German government. She conducted clinical studies on psychosocial treatment of cannabis use disorders (CANDIS-project). MF is head of sector “support to practice” at the European Drugs Agency (EUDA).